Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$988.1M
Avg Funding
$39.5M
Global Reach
6
countries

Top Cities for Biopharma

Foster City
Toulouse
Vestavia Hills
La Jolla
Cambridge
Blue Bell

Recently Funded Companies

Export
Foster City, United States

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

$63.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Toulouse, France

Genoskin is a biotech company that leverages its expertise in skin biology and immunology to enhance the development of medications.

$5.4M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Vestavia Hills, United States

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

$8.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Enlaza Therapeutics is a biotechnology research company.

$15.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

$67.5M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Blue Bell, United States

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

$3.9M raised
Aug 2025

Founder Contacts

30,000+ verified contacts

Södertälje, Sweden

Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptors to treat infectious and autoimmune diseases.

$46.1M raised
Aug 2025

Founder Contacts

30,000+ verified contacts

New York, United States

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

$44.0M raised
Aug 2025

Founder Contacts

30,000+ verified contacts

Palo Alto, United States

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

$372.5M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

Cincinnati, United States

Eikonoklastes is rapidly advancing innovative medicines for numerous areas of significant unmet medical need.

$13.6M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

Palo Alto, United States

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

$30.5M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

Seattle, United States

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

$100.0M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Sequome is a biotechnology company that offers a platform to decodes designs sequences for the development of sequence medicines.

$10.6M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

Bordeaux, France

bYoRNA is cost-efficient, scalable bioproduction of high-quality therapeutic mRNA using eukaryotic cells, particularly recombinant yeast.

$1.8M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

Saint-antoine, France

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

$38.9M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

Andover, United States

Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.

$55.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Laguna Beach, United States

Ryght AI develops an enterprise-scale generative AI platform and applications to accelerate clinical trials.

$3.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Lyon, France

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

$6.9M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Paris, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

$19.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

North Chicago, United States

32 Biosciences is a biotechnology company at the forefront of gut microbiome medicine, focusing on both diagnostics and therapeutics.

$6.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Singapore, Singapore

Nuevocor operates as a preclinical-stage biotech company.

$45.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

Tel Aviv, Israel

AI-Powered Microbiome Intelligence for Human Health

$8.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

Columbus, United States

Armatus Bio is an emerging precision therapeutics company at the intersection of genetic science and bioengineering.

$3.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Florey Biosciences engineers probiotics using synthetic biology for human health.

$1.4M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

San Carlos, United States

Synthetic Design Lab is built to revolutionize antibody-drug conjugates (ADCs) with its novel SYNTHBODYN therapeutic platform.

$20.0M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Showing 451 to 475 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$39.5M
Total Funding Tracked
$988.1M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
2 companies$68.9M
2.Palo Alto
2 companies$403.0M
3.Foster City
1 companies$63.0M
4.Toulouse
1 companies$5.4M
5.Vestavia Hills
1 companies$8.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked